Applied Therapeutics Receives Complete Response Letter From U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

GlobeNewswireNov 27 16:10 ET

Applied Therapeutics Stock Plummets 73%. The FDA Delivers This Crushing Blow. -- Barrons.com

Barron's45minutes ago

RBC Capital Downgrades Applied Therapeutics to Sector Perform, Lowers Price Target to $4

BenzingaNov 29 10:18 ET · Ratings

Applied Therapeutics Analyst Ratings

BenzingaNov 29 10:15 ET · Ratings

Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug

InvestopediaNov 29 10:06 ET

Applied Therapeutics Price Target Lowered to $5 From $14 at Baird

TipRanksNov 29 09:45 ET